Flexotron Cross viscoelastic sterile implant for intra-articular injections based on cross-linked hyaluronic sodium 60mg/3ml, syringe 1pc

Composition

Viscoelastic sterile implant for intra-articular injection Flexotron ® Cross – linked sodium hyaluronate,60 mg / 3.0 ml, in glass syringes.

Indications

The medical device is indicated for the treatment of joint pain in osteoarthritis (OA).

Contraindications

Do not use the implant to treat patients with hypersensitivity to hyaluronate-based products.

Intra-articular injections are contraindicated in the case of past or current infections or skin diseases in the immediate vicinity of the injection site.

Side effects

The main side effects of using the implant are pain, swelling and stiffness in the joint where the injection was made.

How to take, course of use and dosage

The implant is inserted into a joint affected by osteoarthritis (OA) in the volume contained in one syringe designed for one adult patient. Course: intra-articular 1 syringe. The dosage is 3 ml per course of treatment, so adults should enter the entire contents of the syringe. The product remains effective for at least 6 months.

Composition

Flexotron®Description Cross is the first bionic cross-link cross-linked hyaluronic acid preparation for a single injection on the Russian market. Sewn using the patented CHAP technology. It remains in the joint 20 times longer than linear hyaluronic acid. It has an ideal combination of elastic and viscous properties. Easily administered and easily tolerated by patients.

Storage conditions

Store in accordance with the information on the packaging. Acceptable temperature limits are from 2 to 30 degrees. Avoid exposure to sunlight, do not freeze.

Shelf life

3 years

Active ingredient

Sodium Hyaluronate

Conditions of release from pharmacies

Prescription